Paysign, Inc. - Common Stock (PAYS)

Paysign handily beat Wall Street analysts in the first quarter but didn't raise guidance. The stock looks cheap.

Paysign (NASDAQ:PAYS) reported what executives described as the strongest start to a year in the company’s history, with first-quarter 2026 revenue rising 50.8% year over year to $28 million and profitability expanding sharply as its patient affordability business became its largest revenue contribu

Paysign is enjoying an explosive rally today, but the stock is still down slightly in 2026.

Paysign (PAYS) Q4 2025 Earnings Call Transcript

These aren't exactly household names, but they could become much larger in the future.

Paysign (PAYS) Q3 2025 Earnings Call Transcript

Paysign Q3 2025 earnings crush estimates with 41.6% revenue growth. Its high-margin pharma business soared 141.9%, driving strong profitability and a raised 2025 outlook.

Could Paysign (PAYS) be the next big investment opportunity? Join our experts as they break down its strengths, risks, and potential for growth in the competitive payment industry.

3 software stocks, Intrusion, Katapult, & PaySign, surge in momentum rankings, signaling strong price performance in the sector.

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.

PaySign Inc (PAYS) aligns with Mark Minervini’s Trend Model, showing strong technicals, high relative strength, and robust earnings growth, making it a high-momentum stock to watch.